B-lactoglobulin-Modified Mesoporous Silica Nanoparticles, A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostate Cancer Cells

Name: B-lactoglobulin-Modified Mesoporous Silica Nanoparticles, A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostate Cancer Cells
Creator: Queensland University of Technology
License: 暂无描述

Research Data Australia2024-12-14 收录

下载链接：

https://researchdata.edu.au/b-lactoglobulin-modified-cancer-cells/2029694

下载链接

链接失效反馈

官方服务：

资源简介：

Fenbendazole, which is an anthelmintic, was encapsulated into succinylated beta-lactoglobulin-modified, amine-functionalised mesoporous silica nanoparticles to protect the drug throughout gastrointestinal tract and improve its anticancer effects against prostate cancer. The data resulting from this study include the Higuchi kinetic model of the drug release and the toxicity effects of the prepared formulations against HEK-293 cells.

提供机构：

Queensland University of Technology